{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:49:02Z","timestamp":1768434542076,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005821","name":"U.S. Department of Health & Human Services | DHHS Office of the Secretary","doi-asserted-by":"publisher","award":["5R21AG068940-02"],"award-info":[{"award-number":["5R21AG068940-02"]}],"id":[{"id":"10.13039\/100005821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Obesity, impaired glycemic control, and hepatic steatosis often coexist and are risk factors for developing dementia, and Alzheimer\u2019s disease (AD). We hypothesized that a therapeutic agent that improves glycemic control and steatosis may attenuate obesity-associated progression of dementia. We previously identified that adenoviral protein E4orf1 improves glycemic control and reduces hepatic steatosis despite obesity in mice. Here, we determined if this metabolic improvement by E4orf1 will ameliorate cognitive decline in a transgenic mouse model of AD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fourteen- to twenty-month-old APP\/PS1\/E4orf1 and APP\/PS1 (control) mice were fed a high-fat diet. Cognition was determined by Morris Water Maze (MWM). Systemic glycemic control and metabolic signaling changes in adipose tissue, liver, and brain were determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to control, E4orf1 expression significantly improved glucose clearance, reduced endogenous insulin requirement and lowered body-fat, enhanced glucose and lipid metabolism in adipose tissue, and reduced de novo lipogenesis in the liver. In the brain, E4orf1 mice displayed significantly greater expression of genes involved in neurogenesis and amyloid-beta degradation and performed better in MWM testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study opens-up the possibility of addressing glycemic control and steatosis for attenuating obesity-related cognitive decline. It also underscores the potential of E4orf1 for the purpose, which needs further investigations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41387-023-00242-6","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T07:01:42Z","timestamp":1691823702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["E4orf1 improves adipose tissue-specific metabolic risk factors and indicators of cognition function in a mouse model of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Md Shahjalal Hossain","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleigh","family":"Hefner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arubala","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-1064","authenticated-orcid":false,"given":"Nikhil V.","family":"Dhurandhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4160-2764","authenticated-orcid":false,"given":"Vijay","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,12]]},"reference":[{"key":"242_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrendo.2016.135","volume":"13","author":"B Gross","year":"2017","unstructured":"Gross B, Pawlak M, Lefebvre P, Staels B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 2017;13:36\u201349.","journal-title":"Nat Rev Endocrinol"},{"key":"242_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S1474-4422(14)70085-7","volume":"13","author":"AJ Kiliaan","year":"2014","unstructured":"Kiliaan AJ, Arnoldussen IAC, Gustafson DR. Adipokines: a link between obesity and dementia? Lancet Neurol. 2014;13:913\u201323.","journal-title":"Lancet Neurol"},{"key":"242_CR3","doi-asserted-by":"publisher","first-page":"e12802","DOI":"10.1111\/acel.12802","volume":"17","author":"X Xia","year":"2018","unstructured":"Xia X, Jiang Q, McDermott J, Han JJ. Aging and Alzheimer\u2019s disease: comparison and associations from molecular to system level. Aging Cell. 2018;17:e12802.","journal-title":"Aging Cell"},{"key":"242_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.brainresbull.2012.08.003","volume":"89","author":"B Misiak","year":"2012","unstructured":"Misiak B, Leszek J, Kiejna A. Metabolic syndrome, mild cognitive impairment and Alzheimer\u2019s disease\u2014the emerging role of systemic low-grade inflammation and adiposity. Brain Res Bull. 2012;89:144\u20139.","journal-title":"Brain Res Bull"},{"key":"242_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnagi.2020.00017","volume":"12","author":"PBT Pichiah","year":"2020","unstructured":"Pichiah PBT, Sankarganesh D, Arunachalam S, Achiraman S. Adipose-derived molecules\u2013untouched horizons in Alzheimer\u2019s disease biology. Front Aging Neurosci. 2020;12:12\u20137.","journal-title":"Front Aging Neurosci"},{"key":"242_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3233\/JAD-2009-1022","volume":"16","author":"JA Luchsinger","year":"2009","unstructured":"Luchsinger JA, Gustafson DR. Adiposity, type 2 diabetes, and Alzheimer\u2019s disease. J Alzheimers Dis. 2009;16:693\u2013704.","journal-title":"J Alzheimers Dis"},{"key":"242_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ageing\/afv151","volume":"45","author":"E Pedditizi","year":"2016","unstructured":"Pedditizi E, Peters R, Beckett N. The risk of overweight\/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Ageing. 2016;45:14\u201321.","journal-title":"Age Ageing"},{"key":"242_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","volume":"63","author":"JA Luchsinger","year":"2004","unstructured":"Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004;63:1187\u201392.","journal-title":"Neurology"},{"key":"242_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/nu9050492","volume":"9","author":"A Amato","year":"2017","unstructured":"Amato A, Caldara G-F, Nuzzo D, Baldassano S, Picone P, Rizzo M, et al. NAFLD and atherosclerosis are prevented by a natural dietary supplement containing curcumin, silymarin, guggul, chlorogenic acid and inulin in mice fed a high-fat diet. Nutrients 2017;9:492.","journal-title":"Nutrients"},{"key":"242_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","volume":"13","author":"D-G Kim","year":"2016","unstructured":"Kim D-G, Krenz A, Toussaint LE, Maurer KJ, Robinson S-A, Yan A, et al. Non-alcoholic fatty liver disease induces signs of Alzheimer\u2019s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. J Neuroinflammation. 2016;13:1\u201318.","journal-title":"J Neuroinflammation"},{"key":"242_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69:29\u201338.","journal-title":"Arch Neurol"},{"key":"242_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000318845","volume":"30","author":"M Gold","year":"2010","unstructured":"Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders AM, Irizarry M, et al. Rosiglitazone monotherapy in mild-to-moderate Alzheimer\u2019s disease: results from a randomized, double-blind, placebo-controlled phase III study. Dement Geriatr Cogn Disord. 2010;30:131\u201346.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"242_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbamcr.2015.01.017","volume":"1853","author":"P Picone","year":"2015","unstructured":"Picone P, Nuzzo D, Caruana L, Messina E, Barera A, Vasto S, et al. Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-kappaB activation: Use of insulin to attenuate metformin\u2019s effect. Biochim Biophys Acta. 2015;1853:1046\u201359.","journal-title":"Biochim Biophys Acta"},{"key":"242_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3350\/cmh.2020.0137","volume":"26","author":"KS Kim","year":"2020","unstructured":"Kim KS, Lee BW. Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26:430\u201343.","journal-title":"Clin Mol Hepatol"},{"key":"242_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","volume":"77","author":"S Craft","year":"2020","unstructured":"Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, et al. Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial. JAMA Neurol. 2020;77:1099\u2013109.","journal-title":"JAMA Neurol"},{"key":"242_CR16","doi-asserted-by":"publisher","first-page":"e23394","DOI":"10.1371\/journal.pone.0023394","volume":"6","author":"EJ Dhurandhar","year":"2011","unstructured":"Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, Dhurandhar NV. E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS ONE. 2011;6:e23394.","journal-title":"PLoS ONE"},{"key":"242_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.molmet.2015.07.004","volume":"4","author":"CM Kusminski","year":"2015","unstructured":"Kusminski CM, Gallardo-Montejano VI, Wang ZV, Hegde V, Bickel PE, Dhurandhar NV, et al. E4orf1 induction in adipose tissue promotes insulin-independent signaling in the adipocyte. Mol Metab. 2015;4:653\u201364.","journal-title":"Mol Metab"},{"key":"242_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2337\/db16-0876","volume":"66","author":"TB McMurphy","year":"2017","unstructured":"McMurphy TB, Huang W, Xiao R, Liu X, Dhurandhar NV, Cao L. Hepatic expression of adenovirus 36 E4ORF1 improves glycemic control and promotes glucose metabolism through AKT activation. Diabetes 2017;66:358\u201371.","journal-title":"Diabetes"},{"key":"242_CR19","doi-asserted-by":"publisher","first-page":"e0208427","DOI":"10.1371\/journal.pone.0208427","volume":"13","author":"AA Shastri","year":"2018","unstructured":"Shastri AA, Hegde V, Peddibhotla S, Feizy Z, Dhurandhar NV. E4orf1: a protein for enhancing glucose uptake despite impaired proximal insulin signaling. PLoS ONE. 2018;13:e0208427.","journal-title":"PLoS ONE"},{"key":"242_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41387-020-0114-9","volume":"10","author":"M Akheruzzaman","year":"2020","unstructured":"Akheruzzaman M, Hegde V, Shin AC, Dhurandhar NV. Reducing endogenous insulin is linked with protection against hepatic steatosis in mice. Nutr Diabetes. 2020;10:11.","journal-title":"Nutr Diabetes"},{"key":"242_CR21","doi-asserted-by":"publisher","first-page":"e002096.","DOI":"10.1136\/bmjdrc-2020-002096","volume":"9","author":"Z Mostofinejad","year":"2021","unstructured":"Mostofinejad Z, Akheruzzaman M, Abu Bakkar Siddik M, Patkar P, Dhurandhar NV, Hegde V. Antidiabetic E4orf1 protein prevents hepatic steatosis and reduces markers of aging-related cellular damage in high fat fed older mice. BMJ Open Diabetes Res Care. 2021;9:e002096.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"242_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exger.2016.12.019","volume":"88","author":"L Macklin","year":"2017","unstructured":"Macklin L, Griffith CM, Cai Y, Rose GM, Yan XX, Patrylo PR. Glucose tolerance and insulin sensitivity are impaired in APP\/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline. Exp Gerontol. 2017;88:9\u201318.","journal-title":"Exp Gerontol"},{"key":"242_CR23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1:848\u201358.","journal-title":"Nat Protoc"},{"key":"242_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5334\/irsp.82","volume":"30","author":"M Delacre","year":"2017","unstructured":"Delacre M, Lakens D, Leys C. Why psychologists should by default use Welch\u2019s t-test instead of Student\u2019s t-test. Int Rev Soc Psychol. 2017;30:92\u2013101.","journal-title":"Int Rev Soc Psychol"},{"key":"242_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8433","volume":"6","author":"G Abreu-Vieira","year":"2015","unstructured":"Abreu-Vieira G, Fischer AW, Mattsson C, de Jong JMA, Shabalina IG, Ryd\u00e9n M, et al. Cidea improves the metabolic profile through expansion of adipose tissue. Nat Commun. 2015;6:7433.","journal-title":"Nat Commun"},{"key":"242_CR26","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1194\/jlr.RA120000869","volume":"61","author":"Y Zou","year":"2020","unstructured":"Zou Y, Wang Y-N, Ma H, He Z-H, Tang Y, Guo L, et al. SCD1 promotes lipid mobilization in subcutaneous white adipose tissue. J lipid Res. 2020;61:1589\u2013604.","journal-title":"J lipid Res"},{"key":"242_CR27","doi-asserted-by":"publisher","unstructured":"Mann JP, Tabara LC, Alvarez-Guaita A, Dong L, Haider A, Lim K, et al. Loss of Mfn1 but not Mfn2 enhances adipogenesis. bioRxiv 2022.11.04.515167. https:\/\/doi.org\/10.1101\/2022.11.04.515167.","DOI":"10.1101\/2022.11.04.515167"},{"key":"242_CR28","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/oby.2012.19","volume":"20","author":"KL Hildreth","year":"2012","unstructured":"Hildreth KL, Van Pelt RE, Schwartz RS. Obesity, insulin resistance, and Alzheimer\u2019s disease. Obesity. 2012;20:1549\u201357.","journal-title":"Obesity"},{"key":"242_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4172\/2161-0460.1000437","volume":"8","author":"A Gupta","year":"2018","unstructured":"Gupta A, Singh A, Deka R, Gupta R, Jha R. To investigate role of glycosylated hemoglobin (Hba1c) as a biomarker for prediction of dementia and cognitive dysfunction in type 2 diabetic patients. J Alzheimers Dis Parkinsonism. 2018;8:437.","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"242_CR30","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","volume":"98","author":"J Fruebis","year":"2001","unstructured":"Fruebis J, Tsao T-S, Javorschi S, Ebbets-Reed D, Erickson MRS, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001;98:2005\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"242_CR31","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1073\/pnas.0802063105","volume":"105","author":"V Puri","year":"2008","unstructured":"Puri V, Ranjit S, Konda S, Nicoloro SMC, Straubhaar J, Chawla A, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA. 2008;105:7833\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"242_CR32","first-page":"S89","volume":"13","author":"E Gholizadeh","year":"2020","unstructured":"Gholizadeh E, Khaleghian A, Najafgholi Seyfi D, Karbalaei R. Showing NAFLD, as a key connector disease between Alzheimer\u2019s disease and diabetes via analysis of systems biology. Gastroenterol Hepatol Bed Bench. 2020;13:S89\u2013s97.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"242_CR33","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;62:1403\u201316.","journal-title":"J Alzheimers Dis"},{"key":"242_CR34","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta. 2014;1842:1240\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"242_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","volume":"120","author":"B Sheng","year":"2012","unstructured":"Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer\u2019s disease. J Neurochem. 2012;120:419\u201329.","journal-title":"J Neurochem"},{"key":"242_CR36","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: implications for neuronal damage. Hum Mol Genet. 2011;20:2495\u2013509.","journal-title":"Hum Mol Genet"},{"key":"242_CR37","doi-asserted-by":"publisher","first-page":"662774","DOI":"10.3389\/fnmol.2021.662774","volume":"14","author":"S Tutukova","year":"2021","unstructured":"Tutukova S, Tarabykin V, Hernandez-Miranda LR. The role of neurod genes in brain development, function, and disease. Front Mol Neurosci. 2021;14:662774.","journal-title":"Front Mol Neurosci"},{"key":"242_CR38","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1523\/JNEUROSCI.4530-06.2007","volume":"27","author":"G Friocourt","year":"2007","unstructured":"Friocourt G, Liu JS, Antypa M, Rakic S, Walsh CA, Parnavelas JG. Both doublecortin and doublecortin-like kinase play a role in cortical interneuron migration. J Neurosci. 2007;27:3875\u201383.","journal-title":"J Neurosci"},{"key":"242_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0896-6273(00)80778-3","volume":"23","author":"JG Gleeson","year":"1999","unstructured":"Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 1999;23:257\u201371.","journal-title":"Neuron"},{"key":"242_CR40","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/jnr.22387","volume":"88","author":"M Demars","year":"2010","unstructured":"Demars M, Hu Y-S, Gadadhar A, Lazarov O. Impaired neurogenesis is an early event in the etiology of familial Alzheimer\u2019s disease in transgenic mice. J Neurosci Res. 2010;88:2103\u201317.","journal-title":"J Neurosci Res"},{"key":"242_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2012.02.015","volume":"1449","author":"A Hamilton","year":"2012","unstructured":"Hamilton A, Holscher C. The effect of ageing on neurogenesis and oxidative stress in the APPswe\/PS1deltaE9 mouse model of Alzheimer\u2019s disease. Brain Res. 2012;1449:83\u201393.","journal-title":"Brain Res"},{"key":"242_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0197-4580(00)00253-0","volume":"22","author":"VV Shuvaev","year":"2001","unstructured":"Shuvaev VV, Laffont I, Serot J-M, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer\u2019s disease. Neurobiol Aging. 2001;22:397\u2013402.","journal-title":"Neurobiol Aging"},{"key":"242_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-004-0871-x","volume":"108","author":"H Choei","year":"2004","unstructured":"Choei H, Sasaki N, Takeuchi M, Yoshida T, Ukai W, Yamagishi S-i, et al. Glyceraldehyde-derived advanced glycation end products in Alzheimer\u2019s disease. Acta Neuropathol. 2004;108:189\u201393.","journal-title":"Acta Neuropathol"},{"key":"242_CR44","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.mehy.2006.12.017","volume":"69","author":"M Takeuchi","year":"2007","unstructured":"Takeuchi M, Sato T, Takino J-I, Kobayashi Y, Furuno S, Kikuchi S, et al. Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer\u2019s disease. Med Hypotheses. 2007;69:1358\u201366.","journal-title":"Med Hypotheses"},{"key":"242_CR45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-\u03b2 peptide neurotoxicity in Alzheimer\u2019s disease. Nature 1996;382:685\u201391.","journal-title":"Nature"},{"key":"242_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","volume":"36","author":"Z Cai","year":"2016","unstructured":"Cai Z, Liu N, Wang C, Qin B, Zhou Y, Xiao M, et al. Role of RAGE in Alzheimer\u2019s disease. Cell Mol Neurobiol. 2016;36:483\u201395.","journal-title":"Cell Mol Neurobiol"},{"key":"242_CR47","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41366-020-0526-6","volume":"44","author":"Z Feizy","year":"2020","unstructured":"Feizy Z, Peddibhotla S, Khan S, Hegde V, Wang S, Dhurandhar NV. Nanoparticle-mediated in vitro delivery of E4orf1 to preadipocytes is a clinically relevant delivery system to improve glucose uptake. Int J Obes. 2020;44:1607\u201316.","journal-title":"Int J Obes"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00242-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T08:02:08Z","timestamp":1700380928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00242-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1038\/s41387-023-00242-6","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,12]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NVD has several patents in viral obesity and adenovirus 36 including uses for E1A, E4\u2010ORF1 gene and protein, and AKT1inhibitor, and has received grant support for determining antidiabetic properties of E4\u2010ORF1 protein.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}